Proxsys Rx

APRIL 1, 2025

Maximizing pharmacys role in your hospitals revenue cycle The 340B landscape continues to evolve rapidly, with ongoing manufacturer restrictions, new compliance hurdles, and increasing financial pressures on covered entities. Recent estimates indicate that hospitals and clinics collectively lose around $3.2

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Documentation Drug Pricing 52

Drug Channels

MARCH 15, 2022

drug pricing, reimbursement, and dispensing system. The 2022 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers , our 13th edition, provides a comprehensive, fact-based, and non-partisan tool for understanding the entire U.S. The chart below illustrates the depth and breadth of the 2022 edition.

Specialty Pharmacies 98

Specialty Pharmacies Drug Pricing Pharmaceutical Manufacturing Documentation 98

Proxsys Rx

JANUARY 10, 2023

Nobody’s ever put it better than the Association of American Medical Colleges (AAMC): “Congress created the 340B Drug Pricing Program in 1992 to protect safety-net hospitals from escalating drug prices by allowing them to purchase outpatient drugs at a discount from manufacturers. percent to 3.5

Hospitals 52

Hospitals Drug Pricing Pharmaceutical Manufacturing Pharmaceutical Companies 52

Proxsys Rx

OCTOBER 6, 2022

Why specialized software is essential for successful 340B programs As we’ve mentioned in several previous posts, many hospitals taking full advantage of 340B programs’ discounts save millions of dollars a year on prescription costs. Once TPAs have 340B prices, we order the eligible drugs for those 340B programs.

Hospitals 52

Hospitals Drug Pricing Communication Pharmaceutical Manufacturing 52

Viseven

JANUARY 13, 2023

So, at the end of the day, the HEOR’s major task is to make sure that the patients who get access to the new treatment will get the best health outcomes at the most affordable price. HEOR Impact on Drug Pricing and Marketing. Healthcare Institutions – public or private hospitals, healthcare providers, medical centers.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Dosage Drug Pricing 40

Drug Channels

MARCH 18, 2025

Pharmacies and PBMs, Examining $683 Billion Market Review pricing/license options and download the full 2025 report Order before March 31, 2025 to receive special discounted pricing! drug pricing, reimbursement, and dispensing system. prescription drug channels. What's inside?

Specialty Pharmacies 52

Specialty Pharmacies Drug Pricing Pharmaceutical Manufacturing Hospitals 52

European Pharmaceutical Review

FEBRUARY 20, 2025

China and India together supply more than 70 percent of APIs used in US drug manufacturing, while Europe remains a key supplier of high-value biologics and specialised medicines. 3 Additionally, tariffs could increase lead times for manufacturing, as companies navigate customs barriers and seek alternative suppliers.

Drug Pricing 20

Drug Pricing Pharmaceutical Manufacturing Generic Medicine Hospitals 20